Daiichi Sankyo reviews

Company unable to replace revenue lost from two biggest money-making drugs when they go off patent, so 50% of jobs will be eliminated

Male dominated Japanese-influenced culture with lack of diversity. The company's future is shaky, little to no products in the pipeline. Favoritism is rampant but they try to disguise it with HR processes and stated company values. Unfortunately, the company does not have a good reputation in the industry unless it changes.